Fortress biotech, inc. (FBIO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10
Revenue
Product revenue, net

11,946

-

9,492

-

6,125

-

5,168

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue, net

-

-

-

8,199

-

-

-

6,689

5,509

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue - related party

972

25

280

1,051

352

2,981

5

126

394

-

-

-

-

-

-

-

-

-

25

0

500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenue

12,918

11,130

9,772

9,250

6,477

8,991

5,173

6,815

5,903

-125,020

46,886

50,697

44,682

-

975

2,230

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

660

338

25

0

500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gross margin

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses
Cost of goods sold - product revenue

3,810

-

2,702

-

1,884

-

1,406

-

1,472

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of goods sold - product revenue

-

-

-

2,386

-

-

-

1,668

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

14,867

18,881

14,571

18,511

23,273

-

16,082

17,488

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development - licenses acquired

250

4,740

700

200

450

-

3,706

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

15,519

-

14,339

-

13,478

-

12,184

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

34,446

-

32,312

-

39,085

-

33,378

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of goods sold - product revenue

-

-

-

-

-

-

-

-

-

-

-

878

469

-

41

324

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

-

-

-

-

-

-

-

-

24,958

-

-

-

-

-

-

-

-

16,684

9,073

2,411

1,642

-

1,609

2,377

4,487

6,552

5,361

7,795

5,974

4,585

3,777

4,525

4,581

3,442

1,753

2,142

1,246

1,822

Research and development - licenses acquired

-

-

-

-

-

-

-

-

97

1,070

0

1,800

1,294

2,389

1,000

2,060

83

526

1,895

1,548

7,439

0

0

0

0

-

-

-

0

-

-

-

0

0

0

0

20,706

-

General and administrative

-

-

-

13,443

-

-

-

13,056

13,548

-

-

8,524

7,985

-

7,620

6,637

-

4,312

7,129

3,803

3,490

-

2,737

2,386

2,095

2,972

2,143

2,499

2,484

2,671

2,054

1,940

2,000

1,790

1,778

1,594

593

260

Underwriting costs

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

-

34,540

-

-

-

32,213

40,075

-108,597

79,489

73,890

62,259

31,852

17,221

17,366

15,751

12,964

18,097

7,762

12,571

4,961

4,346

4,763

6,582

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from operations

-21,528

-30,381

-22,540

-25,290

-32,608

-32,222

-28,205

-25,398

-34,172

-16,423

-32,603

-23,193

-17,577

-19,237

-16,246

-15,136

-15,091

-12,626

-18,072

-7,762

-12,071

-4,961

-4,346

-4,763

-6,582

-9,524

-7,504

-10,294

-8,458

-8,299

-5,831

-6,465

-6,581

-5,232

-3,531

-3,736

-22,545

-2,082

Other income (expense)
Interest income

627

604

738

779

438

263

269

294

278

289

204

190

136

57

89

77

75

50

39

74

82

145

168

171

178

-

-

109

76

84

79

29

44

54

70

22

19

24

Interest expense and financing fee

3,125

3,106

3,168

3,106

2,469

2,690

2,657

2,590

2,403

2,389

3,220

1,380

698

1,852

689

529

620

-

350

352

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense and financing fee

3,125

3,106

3,168

3,106

2,469

2,690

2,657

2,590

2,403

2,389

3,220

1,380

698

1,852

689

529

620

-

350

352

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

331

-

121

119

966

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

42

-

-

-

0

796

-12

-79

-23

5,523

639

-1,452

-4,342

934

16

0

89

438

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of subsidiary convertible note

-

-

-

-

-

411

-84

-140

250

-98

-74

-188

-97

-65

-13

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of subsidiary convertible note

-

-

-

-

-

411

-84

-140

250

-98

-74

-188

-97

-65

-13

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

165

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

493

485

476

449

183

19

19

19

19

19

17

62

Change in fair value of investments

-

-

-

-

-

0

-565

-707

-118

467

270

157

-668

729

-81

-801

-918

-1,610

-1,472

1,622

-215

1,235

-293

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on deconsolidation of Caelum

0

-45

0

137

18,384

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-333

-

-

-

13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expenses

-

-

-

-

-

-

-

-

-

-

245

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of short-term investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

Total other income (expense)

-2,540

-2,574

-2,430

-2,190

16,353

-2,411

-3,025

-3,397

-1,970

-7,272

-3,704

244

3,015

-2,065

-710

-1,253

-1,552

-2,449

-1,783

1,344

-464

1,248

-246

52

-788

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations

-

-

-24,970

-27,480

-

-34,633

-31,230

-28,795

-36,142

-

-36,307

-22,949

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations:
Loss from discontinued operations, net of tax

-

-

-

-

-

-7,115

2,643

-6,921

-2,076

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total loss from discontinued operations

-

-

-

-

-

-4,782

2,643

-6,921

-2,076

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-24,068

-32,955

-24,970

-27,480

-16,255

-39,415

-28,587

-35,716

-38,218

-26,018

-36,307

-22,949

-14,562

-21,302

-16,956

-16,389

-16,643

-15,075

-19,855

-6,418

-12,535

-3,713

-4,592

-4,711

-7,370

-

-

-

-

-

-

-

-

-

-

-

-

-

Less: net loss attributable to non-controlling interests

-11,698

-17,463

-12,208

-14,382

-17,647

-14,535

-11,949

-14,105

-17,200

-15,605

-9,191

-5,584

-2,580

-3,871

-3,975

-3,911

-4,438

-3,039

-1,694

-243

-479

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-115

-

-

-

Net income (loss) attributable to common stockholders

-12,370

-15,492

-12,762

-13,098

1,392

-24,880

-16,638

-21,611

-21,018

-10,413

-27,116

-17,365

-11,982

-17,431

-12,981

-12,478

-12,205

-12,036

-18,161

-6,175

-12,056

-3,713

-4,592

-4,711

-7,370

-9,798

-7,832

-10,670

-8,858

-8,664

-5,935

-6,455

-6,556

-6,719

-3,365

-3,733

-22,543

-2,120

Net loss per common share - basic

-0.38

-

-

-

-0.34

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per common share - diluted

-0.38

-

-

-

-0.25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations per common share - basic and diluted

-

-

-0.44

-0.51

-

-0.80

-0.70

-0.66

-0.85

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations per common share - basic and diluted

-

-

-

-

-

-0.11

0.06

-0.16

-0.05

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per common share attributable to common stockholders - basic

-0.19

-

-

-

0.03

-

-

-

-0.49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per common share attributable to common stockholders - diluted

-0.19

-

-

-

0.02

-

-

-

-0.49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding - basic

63,496

-

-

-

48,506

-

-

-

42,518

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding - diluted

63,496

-

-

-

63,811

-

-

-

42,518

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common Stock dividend to Series A Convertible Preferred Stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-5,861

-

-

Net loss attributed to Common Stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,858

-

-5,935

-6,455

-6,556

-6,719

-3,365

-9,594

-22,543

-2,120

Net loss per common share attributable to common stockholders - basic and diluted

-

-

-0.22

-0.24

-

-

-0.37

-0.50

-

-0.21

-0.67

-0.43

-0.30

-0.44

-0.32

-0.31

-0.31

-0.31

-0.46

-0.16

-0.31

-0.09

-0.13

-0.13

-0.21

-0.25

-0.24

-0.38

-0.35

-0.34

-0.24

-0.34

-0.35

1.32

-0.48

-1.64

-4.71

-0.44

Weighted average common shares outstanding - basic and diluted

-

-

56,856

53,726

-

-

44,818

43,377

-

45,001

40,724

40,551

40,357

40,196

40,128

39,867

39,658

39,479

39,412

39,119

38,574

37,363

36,024

36,005

35,900

35,806

32,634

28,095

25,182

24,445

24,375

19,194

18,604

12,984

7,028

5,848

4,791

4,791